Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15354-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15354-1-AP, RRID:AB_2147773
- Product name
- MYL9 antibody
- Antibody type
- Polyclonal
- Description
- MYL9 antibody (Cat. #15354-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Network pharmacology combined with an animal model to reveal the material basis and mechanism of Amomum villosum in alleviating constipation in mice.
PRPF19 facilitates colorectal cancer liver metastasis through activation of the Src-YAP1 pathway via K63-linked ubiquitination of MYL9.
Paracrine HB-EGF signaling reduce enhanced contractile and energetic state of activated decidual fibroblasts by rebalancing SRF-MRTF-TCF transcriptional axis.
Proteomic profiling of concurrently isolated primary microvascular endothelial cells, pericytes, and vascular smooth muscle cells from adult mouse heart.
Brain-derived neurotrophic factor regulates LYN kinase-mediated myosin light chain kinase activation to modulate nonmuscle myosin II activity in hippocampal neurons.
Transient expansion and myofibroblast conversion of adipogenic lineage precursors mediate bone marrow repair after radiation.
Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer.
Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38‑MAPK signaling pathway.
Liu S, Zhao Y, Li S, Li Y, Liu L, Sheng J, Tian Y, Gao X
Gene 2024 Mar 1;897:148064
Gene 2024 Mar 1;897:148064
PRPF19 facilitates colorectal cancer liver metastasis through activation of the Src-YAP1 pathway via K63-linked ubiquitination of MYL9.
Zhou R, Chen J, Xu Y, Ye Y, Zhong G, Chen T, Qiu L
Cell death & disease 2023 Apr 8;14(4):258
Cell death & disease 2023 Apr 8;14(4):258
Paracrine HB-EGF signaling reduce enhanced contractile and energetic state of activated decidual fibroblasts by rebalancing SRF-MRTF-TCF transcriptional axis.
Afzal J, Du W, Novin A, Liu Y, Wali K, Murthy A, Garen A, Wagner G, Kshitiz
Frontiers in cell and developmental biology 2022;10:927631
Frontiers in cell and developmental biology 2022;10:927631
Proteomic profiling of concurrently isolated primary microvascular endothelial cells, pericytes, and vascular smooth muscle cells from adult mouse heart.
Cao Z, Minnier J, Liu L, Scott KLL, Reddy AP, Wilmarth PA, David LL, Barnes AP, Grafe MR, Kaul S, Alkayed NJ, Davis CM
Scientific reports 2022 May 25;12(1):8835
Scientific reports 2022 May 25;12(1):8835
Brain-derived neurotrophic factor regulates LYN kinase-mediated myosin light chain kinase activation to modulate nonmuscle myosin II activity in hippocampal neurons.
Li X, Yuan RR, Wang Q, Chai S, Zhang Z, Wang Y, Huang SH
The Journal of biological chemistry 2022 Jun;298(6):102054
The Journal of biological chemistry 2022 Jun;298(6):102054
Transient expansion and myofibroblast conversion of adipogenic lineage precursors mediate bone marrow repair after radiation.
Zhong L, Yao L, Holdreith N, Yu W, Gui T, Miao Z, Elkaim Y, Li M, Gong Y, Pacifici M, Maity A, Busch TM, Joeng KS, Cengel K, Seale P, Tong W, Qin L
JCI insight 2022 Apr 8;7(7)
JCI insight 2022 Apr 8;7(7)
Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer.
He F, Ding H, Zhou Y, Wang Y, Xie J, Yang S, Zhu Y
Frontiers in medicine 2021;8:792740
Frontiers in medicine 2021;8:792740
Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38‑MAPK signaling pathway.
Zhang L, Huang D, Shao D, Liu H, Zhou Q, Gui S, Wei W, Wang Y
Oncology reports 2018 Jul;40(1):518-526
Oncology reports 2018 Jul;40(1):518-526
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human colon tissue were subjected to SDS PAGE followed by western blot with 15354-1-AP(MYL9 antibody) at dilution of 1:400
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of MCF-7 cells, using MYL9 antibody 15354-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 15354-1-AP(MYL9 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 15354-1-AP(MYL9 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
